Dubuisson Jean, Helle François, Cocquerel Laurence
Institut de Biologie de Lille (UMR8161), CNRS, Université de Lille I and II and Institut Pasteur de Lille, Lille, France.
Cell Microbiol. 2008 Apr;10(4):821-7. doi: 10.1111/j.1462-5822.2007.01107.x. Epub 2007 Dec 13.
To replicate its genome, a virus needs to cross the plasma membrane of a host cell and get access to cytosolic and/or nuclear components. For an enveloped virus, this involves binding to the plasma membrane, followed by migration of the virion to a microdomain or an endosomal vesicle where fusion between the virion envelope and a host cell membrane occurs. Increasing evidences indicate that virus entry is a tightly regulated process. Although we are still far from understanding the details of hepatitis C virus (HCV) entry, recent data show that this virus enters into target cells in a slow and complex multistep process involving the presence of several entry factors. Initial attachment of the virion may involve glycosaminoglycans and the low-density lipoprotein receptor, and it is followed by the sequential interaction with the scavenger receptor class B type I, the tetraspanin CD81 and tight junction protein Claudin-1, -6 or -9. Furthermore, the identification of EWI-2wint as a new partner of CD81 which blocks E2-CD81 interaction provides additional evidence of the complexity of the HCV entry process. The current knowledge accumulated on HCV entry is summarized in this review.
为了复制其基因组,病毒需要穿过宿主细胞的质膜并接触胞质和/或核成分。对于包膜病毒而言,这涉及与质膜结合,随后病毒粒子迁移至微结构域或内体囊泡,在此处病毒粒子包膜与宿主细胞膜发生融合。越来越多的证据表明,病毒进入是一个受到严格调控的过程。尽管我们距离了解丙型肝炎病毒(HCV)进入的细节仍有很大差距,但最近的数据显示,该病毒以缓慢且复杂的多步骤过程进入靶细胞,这一过程涉及多种进入因子。病毒粒子的初始附着可能涉及糖胺聚糖和低密度脂蛋白受体,随后依次与B类I型清道夫受体、四跨膜蛋白CD81以及紧密连接蛋白Claudin-1、-6或-9相互作用。此外,EWI-2wint作为CD81的新伙伴被鉴定出来,它可阻断E2-CD81相互作用,这为HCV进入过程的复杂性提供了更多证据。本综述总结了目前在HCV进入方面积累的知识。